Related references
Note: Only part of the references are listed.Acute Respiratory Failure Associated With Vaping
Craig Fryman et al.
CHEST (2020)
Association of Hypnotic Drug Use with Fall Incidents in Hospitalized Elderly Patients: A Case-Crossover Study
Haruki Torii et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2020)
Cannabinoid therapies in the management of sleep disorders: A systematic review of preclinical and clinical studies
Anastasia S. Suraev et al.
SLEEP MEDICINE REVIEWS (2020)
Respiratory safety of lemborexant in healthy adult and elderly subjects with mild obstructive sleep apnea: A randomized, double-blind, placebo-controlled, crossover study
Jocelyn Y. Cheng et al.
JOURNAL OF SLEEP RESEARCH (2020)
Association of eszopiclone, zaleplon, or zolpidem with complex sleep behaviors resulting in serious injuries, including death
Kelly Harbourt et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2020)
Clinical pharmacology, efficacy, and safety of orexin receptor antagonists for the treatment of insomnia disorders
Clemens Muehlan et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2020)
Non-GABA sleep medications, suvorexant as risk factors for falls: Case-control and case-crossover study
Yoshiki Ishibashi et al.
PLOS ONE (2020)
Cannabinoids in the Treatment of Insomnia Disorder: A Systematic Review and Meta-Analysis
Chiranth Bhagavan et al.
CNS DRUGS (2020)
American Geriatrics Society 2019 Updated AGS Beers Criteria® for Potentially Inappropriate Medication Use in Older Adults
Donna M. Fick et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2019)
Withdrawal from long-term use of zopiclone, zolpidem and temazepam may improve perceived sleep and quality of life in older adults with primary insomnia
Ritva Lahteenmaki et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2019)
Comparison of Lemborexant With Placebo and Zolpidem Tartrate Extended Release for the Treatment of Older Adults With Insomnia Disorder A Phase 3 Randomized Clinical Trial
Russell Rosenberg et al.
JAMA NETWORK OPEN (2019)
Insomnia in the Elderly: A Review
Dhaval Patel et al.
JOURNAL OF CLINICAL SLEEP MEDICINE (2018)
GABA(A) receptor: Positive and negative allosteric modulators
Richard W. Olsen
NEUROPHARMACOLOGY (2018)
Use of Sedative-Hypnotics and Mortality: A Population-Based Retrospective Cohort Study
Jae-Won Choi et al.
JOURNAL OF CLINICAL SLEEP MEDICINE (2018)
Z-drugs and risk for falls and fractures in older adults-a systematic review and meta-analysis
Nir Treves et al.
AGE AND AGEING (2018)
Clinical Practice Guideline for the Pharmacologic Treatment of Chronic Insomnia in Adults: An American Academy of Sleep Medicine Clinical Practice Guideline
Michael J. Sateia et al.
JOURNAL OF CLINICAL SLEEP MEDICINE (2017)
Lemborexant, A Dual Orexin Receptor Antagonist (DORA) for the Treatment of Insomnia Disorder: Results From a Bayesian, Adaptive, Randomized, Double-Blind, Placebo-Controlled Study
Patricia Murphy et al.
JOURNAL OF CLINICAL SLEEP MEDICINE (2017)
Trends in prescribing of sedative-hypnotic medications in the USA: 1993-2010
Christopher N. Kaufmann et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2016)
MT1 and MT2 Melatonin Receptors: A Therapeutic Perspective
Jiabei Liu et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 56 (2016)
Association between Benzodiazepine Use and Dementia: A Meta-Analysis
GuoChao Zhong et al.
PLOS ONE (2015)
An Observational Study of Insomnia and Nightmare Treated With Trazodone in Patients With Advanced Cancer
Hitoshi Tanimukai et al.
AMERICAN JOURNAL OF HOSPICE & PALLIATIVE MEDICINE (2013)
Hypnotics and mortality in an elderly general population: a 12-year prospective study
Isabelle Jaussent et al.
BMC MEDICINE (2013)
Sleep driving: Sleepwalking variant or misuse of z-drugs?
Mark R. Pressman
SLEEP MEDICINE REVIEWS (2011)
Hypnotic use for insomnia management in chronic obstructive pulmonary disease
Thomas Roth
SLEEP MEDICINE (2009)
Effects of ramelteon on patient-reported sleep latency in older adults with chronic insomnia
Thomas Roth et al.
SLEEP MEDICINE (2006)
Sequential combinations of drug and cognitive behavioral therapy for chronic insomnia:: An exploratory study
A Vallières et al.
BEHAVIOUR RESEARCH AND THERAPY (2005)
Valerian-hops combination and diphenhydramine for treating insomnia: A randomized placebo-controlled clinical trial
CM Morin et al.
SLEEP (2005)
Effects of exogenous melatonin on sleep: a meta-analysis
A Brzezinski et al.
SLEEP MEDICINE REVIEWS (2005)
Persistence of cognitive effects after withdrawal from long-term benzodiazepine use: a meta-analysis
MJ Barker et al.
ARCHIVES OF CLINICAL NEUROPSYCHOLOGY (2004)
Abuse and dependence potential for the non-benzodiazepine hypnotics zolpidem and zopiclone:: a review of case reports and epidemiological data
G Hajak et al.
ADDICTION (2003)
Confirmation of the neurophysiologically predicted therapeutic effects of trazodone on its target symptoms depression, anxiety and insomnia by postmarketing clinical studies with a controlled-release formulation in depressed outpatients
GM Saletu-Zyhlarz et al.
NEUROPSYCHOBIOLOGY (2003)
Secondary insomnia: diagnostic challenges and intervention opportunities
CS McCrae et al.
SLEEP MEDICINE REVIEWS (2001)
Share Paper
